Their study results revealed a positivity rate for the apoA2-i Index of 66.7% in patients with IPMN with high-grade dysplasia, suggesting its potential utility in the early diagnosis of malignant lesions arising from IPMN. This evidence concerns the gene APOA2 and pancreatic intraductal papillary-mucinous neoplasm.